Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 255811생성일: 2026년 10월 27일
1-Butanol → 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-propyl-, (S)-
https://huagongshe.com/reaction/255811
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 1-Butanol | HCID 263 | — |
| 반응물 | Hydrogen Peroxide | HCID 784 | — |
| 반응물 | Sulfuric Acid | HCID 1118 | — |
| 반응물 | Camptothecin | HCID 24360 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-propyl-, (S)- | HCID 149612 | — |
반응 단계
Ferrous sulfate heptahydrate (2.8 g, 10.1 m-mol) and 1-butanol (3 ml, 43 m-mol) were dissolved in water (30 ml). Camptothecin (500 mg, 1.43 m-mol) was suspended in the solution and dissolved therein by addition of concentrated sulfuric acid (15 ml). To this solution was added dropwise under ice-cooling and agitation a 30% aqueous solution of hydrogen peroxide (1.1 ml, 10.1 m-mol) in small portions. The agitation was continued for 4 hours at room temperature. The reaction mixture was diluted with ice water (1.5 l) and extracted with chloroform (2 l). The chloroform layer was dried with magnesium sulfate, filtered and evaporated until dryness under reduced pressure. The residue was subjected to column chromatography (chloroform) through silica gel (15 g) to effect separation and purification of the product which was then recrystallized from n-hexane-chloroform whereby 110 mg (21.0%) of the objective compound were obtained as light yellow white needle crystals. M.P. 260°-261° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | USRE032518 |
|---|
| 출처 데이터셋 | uspto-grants-1987_10 |
|---|
| ORD ID | ord-79a77d71353d483fafa1842e7a6b9e16 |
|---|
| 출처 메모 | uspto-grants-1987_10 |
|---|